Rest-Of-GCC-Countries Protein Expression Market Size, Share,Trends, Growth Analysis Report, 2031

Name: Rest-Of-GCC-Countries Protein Expression Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Rest Of GCC Countries Protein Expression Market analysis

Part of: Protein Expression Market (Global)

The Rest Of GCC Countries Protein Expression Market was valued at $14.1 Million in 2026 and projected to reach to $19.4 Million by 2031, representing a compound annual growth rate of CAGR 6.6%. Rest Of GCC Countries protein expression market is positioned for measured but sustainable growth through 2031.

Rest Of GCC Countries Protein Expression Market (2026-2031) : Size and Share

CAGR of

USD Million

Rest Of GCC Countries Protein Expression Market Trends and Insights

Rest Of GCC Countries is positioned as an emerging hub for biopharmaceutical development, driven by increasing investments in research infrastructure and biotechnology capabilities.
By 2031, Rest Of GCC Countries is projected to reach a market size of $19.4 million, reflecting a compound annual growth rate of 6.6%. Rest Of GCC Countries benefits from regional economic diversification initiatives and growing demand for advanced protein expression technologies in pharmaceutical manufacturing.
The market in Rest Of GCC Countries is supported by rising healthcare expenditure and government backing for life sciences sectors.
Rest Of GCC Countries' protein expression market is expected to expand as local and international biopharmaceutical companies establish production facilities and research centers throughout the forecast period..

Key Market Statistics

CAGR (2026-2031) CAGR 6.6%
Market Size, 2026 ~USD 14.1 Million
Forecast, 2031 ~USD 19.4 Million
Country Rest Of GCC Countries

Rest Of GCC Countries Protein Expression Market Overview

Steady Regional Growth :

Rest Of GCC Countries protein expression market is expanding at 6.6% CAGR, growing from $14.1 million in 2026 to $19.4 million by 2031, demonstrating consistent market momentum in the region.

Emerging Biotech Hub :

Rest Of GCC Countries is establishing itself as a key biopharmaceutical development center, supported by government initiatives and private sector investments in research infrastructure and biotechnology capabilities.

Infrastructure Investment :

Increasing capital allocation toward research facilities and laboratory infrastructure in Rest Of GCC Countries is creating favorable conditions for protein expression technology adoption and innovation.

Growth Below Global Average :

While Rest Of GCC Countries shows solid growth at 6.6% CAGR, it trails the global protein expression market growth rate of 8.3%, indicating untapped expansion potential in the region.

Rest Of GCC Countries Protein Expression Market Dynamics

The region's strategic focus on developing biopharmaceutical capabilities and attracting research investments creates a favorable environment for market expansion.
Government support for biotechnology infrastructure and increasing collaboration with international research institutions are key drivers strengthening the market foundation. The projected growth to $19.4 million by 2031 reflects growing demand for protein expression technologies in drug development and therapeutic manufacturing.
As Rest Of GCC Countries continues to build its scientific ecosystem and regulatory frameworks, the market is expected to attract more biotech companies and research organizations, positioning the region as an increasingly important player in the broader Middle Eastern life sciences landscape..

Related Ecosystem

Biotechnology

Top Technologies

Reagents
Polymerase Chain Reaction (PCR)
Stem Cells
Assay Kits
Flow Cytometers

Top Companies

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.

Key Takeaways

Rest Of GCC Countries protein expression market valued at $14.1 million in 2026, growing to $19.4 million by 2031
Rest Of GCC Countries demonstrates a 6.6% CAGR, reflecting steady regional demand for biopharmaceutical technologies
Rest Of GCC Countries is attracting investment in research infrastructure and manufacturing capabilities for protein-based therapeutics
Rest Of GCC Countries' market growth is supported by government diversification initiatives and increased healthcare spending

Protein Expression Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	SOFTWARE (Type)
Forecast Period	2026�2031
Growth Rate	CAGR of 8.3% from 2026 to 2031
Largest Segment	PRODUCTS (Offering)
Market Size Base Year (Billions)	~USD 5.13 (2026)
Revenue Forecast (Billions)	~USD 7.65 (2031)
Segments Covered	Offering, Type, End User, Workflow, Scale Of Operation, Protein Modality, Application

Rest Of GCC Countries Protein Expression Market Report Segmentation

7 segment dimensions are covered across the global market.

By Offering

Products
Services

By Type

Algal & Plant-Based Expression Systems
Algal-Based Expression Systems
Analytical Instruments
Bacillus Systems
Baculovirus Systems
Bioreactors & Fermenters
Cell-Free Expression Systems
Cho Cell Systems
Chromatography & Purification Consumables
Chromatography Systems
Cld Services
Cloning & Mutagenesis Kits
Competent Cells
Consumables
Culture Media & Supplements
Custom Protein Expression Services
E. Coli Lysate-Based Systems
E. Coli Systems
Expression Kits
Expression Vectors & Plasmids
Filtration & Separation Consumables
Filtration Systems
Gene Synthesis & Cloning Services
Hek 293 Cell Systems
Insect Cell Expression Systems
Instruments
Kits
Liquid Handling & Automation Systems
Mammalian Cell Expression Systems
Other Cell-Free Expression Systems
Other Consumables
Other Insect Cell Expression Systems
Other Instruments
Other Kits
Other Mammalian Cell Expression Systems
Other Prokaryotic Expression Systems
Other Reagents
Other Yeast Expression Systems
Pichia Systems
Process Development & Scale-Up Services
Prokaryotic Expression Systems
Reagents
Saccharomyces Systems
Software
Transduction & Transfection Reagents
Yeast Expression Systems

By End User

Academic & Research Institutes
Cros & Cdmos
Other End Users
Pharmaceutical & Biotechnology Companies

By Workflow

Cloning & Transfection
Extraction, Purification, And Characterization
Transcription, Translation, And Post-Translational Modification (Ptm)

By Scale Of Operation

Discovery & Research Scale
Preclinical & Characterization Scale
Process Development & Pilot Scale

By Protein Modality

Enzymes & Catalytic Proteins
Monoclonal Antibodies & Derivatives
Other Proteins
Recombinant Therapeutic Proteins
Vaccines

By Application

Diagnostic Applications
Industrial Applications
Research Applications
Therapeutic Applications

Target Audience

Biopharmaceutical Companies : Evaluate market entry opportunities and expansion potential in Rest Of GCC Countries, assess local demand for protein expression services, and identify partnership and acquisition targets in the emerging biotech ecosystem.
Research & Development Institutions : Understand regional investment trends, infrastructure development, and collaboration opportunities in Rest Of GCC Countries to guide research initiatives, funding applications, and technology adoption strategies.
Healthcare Investors & Venture Capitalists : Assess investment potential and growth trajectory in Rest Of GCC Countries protein expression market, identify promising startups and established players, and evaluate risk-return profiles for portfolio allocation.
Government & Policy Makers : Leverage market data to inform biotechnology policy development, infrastructure investment decisions, and regulatory frameworks that support protein expression industry growth in Rest Of GCC Countries.
Service & Equipment Providers : Identify market demand, customer segments, and sales opportunities for protein expression technologies and services in Rest Of GCC Countries, supporting product development and go-to-market strategies.

Key Companies in the Rest Of GCC Countries Protein Expression Market

Company	HQ	Ownership	Strongest segments
PATHEON INC	Netherlands	Private Company	Drug Product Services (finished dosage manufacturing & packaging),Pharmaceutical Development Services,Drug Substance Services (small- and large-molecule APIs),
NANOSTRING TECHNOLOGIES, INC	United States	Private Company	nCounter instruments and consumables (Pro, FLEX, SPRINT, CodeSets, panels, reagents),GeoMx DSP and spatial biology solutions,Prosigna and other in vitro diagnostic kits,
BIOGEN	United States	Public Company	Multiple Sclerosis therapies (TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, OCREVUS-related),SPINRAZA and rare neuromuscular (SPINRAZA, QALSODY, SKYCLARYS),Alzheimer�s and neuropsychiatry (LEQEMBI, ZURZUVAE),
SIGMA-ALDRICH CORPORATION	United States	Private Company	Pharma and biopharma manufacturing (media, filtration, critical raw materials, safety testing),Research reagents and molecular biology (chemicals, biochemicals, functional genomics, protein biology),Analytical chemistry, diagnostics, and industrial microbiology,
VIVA BIOTECH LTD	China	Public Company	Discovery biology & structural biology services,Medicinal and synthetic chemistry & CADD,CDMO & CMC/filing services,
CODEXIS, INC.	United States	Public Company	Biopharma process enzymes and custom engineering (CodeEvolver-based),ECO Synthesis and nucleic acid manufacturing solutions,Other life science and industrial enzyme applications,
MAXCYTE, INC	United States	Public Company	ExPERT ATx instruments and related consumables,ExPERT STx instruments and related consumables,ExPERT GTx instruments and related consumables,
THERMO FISHER SCIENTIFIC INC.	United States	Public Company	Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
MERCK KGAA	Germany	Public Company	Life Science (reagents, consumables, bioprocessing, CDMO),Healthcare (oncology, neurology, fertility, rare diseases),Electronics (semiconductor and display materials, delivery equipment),
DANAHER CORPORATION	United States	Public Company	Biotechnology (bioprocessing and bioproduction),Life Sciences (research and analytical instruments, genomics),Diagnostics (clinical instruments and consumables),
AGILENT TECHNOLOGIES, INC.	United States	Public Company	Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
SARTORIUS AG	Germany	Public Company	Bioprocess solutions (bioreactors, cell culture, fluid management, process filtration),Analytical solutions (BLI, cytometry screening, PAT, live-cell imaging, SPR),Lab products and services (filtration, purification, lab water, weighing, pipettes, microbiological testing),
GENSCRIPT	Hong Kong	Public Company	Life Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products,
TAKARA BIO INC.	Japan	Private Company	Genetic and cellular research reagents,Instruments and cellular analysis devices,In vitro diagnostics (including COVID-19),
BIO-RAD LABORATORIES, INC.	United States	Public Company	Clinical Diagnostics,Life Science Research Instruments and Reagents,Other / Software and Services,
QIAGEN	Netherlands	Public Company	Sample technologies (extraction and purification consumables/instruments),PCR and enzymes (qPCR/dPCR instruments and reagents),Molecular diagnostic assays (TB, oncology, sexual and reproductive health, transplant/viral load),
CHARLES RIVER LABORATORIES	United States	Public Company	Research Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
CORNING INCORPORATED	United States	Public Company	Optical communications (fiber, cable, hardware, equipment),Display glass substrates (LCD/OLED),Specialty materials and mobile consumer electronics glass,
LONZA	Switzerland	Public Company	Integrated Biologics (mammalian and drug product CDMO),Advanced Synthesis (small molecules, HPAPIs, ADCs, bioconjugates),Specialized Modalities (cell & gene, microbial, bioscience, mRNA),
FUJIFILM HOLDINGS CORPORATION	Japan	Public Company	Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, image sensors, functional films, storage),Business Innovation (office equipment, document services, graphic communications),
SYNGENE INTERNATIONAL LIMITED	India	Public Company	Discovery Services (chemistry, biology, computational),Development Services (preclinical, CMC, clinical development),Biologics and Specialty Modalities,
LGC LIMITED	South Korea	Public Company	Ethylene-based synthetic resins (PE, EVA, LLDPE, UNIQABLE),Styrene-based resins (ABS, ASA, PS, EPS, SAN),Polycarbonate and engineering plastics (LUMID/LUXY, LUMILOY, LUPOL, LUPOY, etc.),

PATHEON INC

Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.

NANOSTRING TECHNOLOGIES, INC

NanoString Technologies, Inc is a United States-based private company founded in 2003 with 550 employees specializing in life sciences technology.

BIOGEN

Biogen is a United States-based public company founded in 1978 with 7,500 employees engaged in biotechnology and pharmaceutical development.

SIGMA-ALDRICH CORPORATION

Sigma-Aldrich Corporation is a United States-based private company founded in 1951 with 9,800 employees providing life sciences products and services.

VIVA BIOTECH LTD

Viva Biotech Ltd is a China-based public company founded in 2008 with 2,169 employees providing drug discovery and development services.

CODEXIS, INC.

Codexis, Inc is a United States-based public company founded in 2002 with 146 employees focused on enzyme engineering and biocatalysis.

MAXCYTE, INC

MaxCyte, Inc is a United States-based public company founded in 1998 with 91 employees specializing in cell engineering technology.

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc is a United States-based public company founded in 1956 with 125,000 employees serving the life sciences and laboratory sectors globally.

MERCK KGAA

Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating as a diversified pharmaceutical and chemical company.

DANAHER CORPORATION

Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees engaged in life sciences, diagnostics, and environmental solutions.

AGILENT TECHNOLOGIES, INC.

Agilent Technologies, Inc is a United States-based public company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

SARTORIUS AG

Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees specializing in laboratory and bioprocess equipment.

GENSCRIPT

GenScript is a Hong Kong-based public company founded in 2002 with 6,165 employees providing biotechnology research services and products.

TAKARA BIO INC.

Takara Bio Inc is a Japan-based private company founded in 2002 with 1,779 employees specializing in biotechnology research tools and services.

BIO-RAD LABORATORIES, INC.

Bio-Rad Laboratories, Inc is a United States-based public company founded in 1952 with 7,450 employees manufacturing life sciences research and clinical diagnostics products.

QIAGEN

Qiagen is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and life sciences research solutions.

CHARLES RIVER LABORATORIES

Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services.

CORNING INCORPORATED

Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass and materials for life sciences applications.

LONZA

Lonza is a Switzerland-based public company founded in 1897 with 20,000 employees providing pharmaceutical and biotechnology manufacturing services.

FUJIFILM HOLDINGS CORPORATION

Fujifilm Holdings Corporation is a Japan-based public company founded in 1934 with 73,526 employees operating across imaging, pharmaceuticals, and life sciences sectors.

SYNGENE INTERNATIONAL LIMITED

Syngene International Limited is an India-based public company founded in 1993 with 6,692 employees providing drug discovery and development services.

LGC LIMITED

LGC Limited is a South Korea-based public company founded in 1947 with 14,019 employees operating in life sciences and analytical testing services.

Reasons to Buy this Report

Regional Market Sizing : Obtain precise market valuation for Rest Of GCC Countries protein expression sector with verified 2026-2031 projections, enabling accurate business planning and investment decisions specific to this emerging market.
Growth Opportunity Assessment : Understand the 6.6% CAGR trajectory and $5.3 million market expansion opportunity in Rest Of GCC Countries, identifying optimal entry points and expansion strategies for biotech companies and service providers.
Competitive Positioning : Benchmark Rest Of GCC Countries market performance against global 8.3% CAGR to identify competitive advantages and gaps, informing strategic positioning in this developing biopharmaceutical hub.
Infrastructure Investment Insights : Access detailed analysis of research infrastructure development and government initiatives driving protein expression adoption in Rest Of GCC Countries, supporting investment and partnership decisions.
Stakeholder Intelligence : Equip leadership, investors, and business development teams with comprehensive Rest Of GCC Countries market data to support funding proposals, market entry strategies, and regional expansion planning.

Frequently asked questions

What is the current market size of protein expression in Rest Of GCC Countries?

Rest Of GCC Countries' protein expression market is estimated at $14.1 million in 2026.

What is the projected market size for Rest Of GCC Countries by 2031?

Rest Of GCC Countries' protein expression market is forecast to reach $19.4 million by 2031.

What is the CAGR for Rest Of GCC Countries protein expression market?

Rest Of GCC Countries' protein expression market is expected to grow at a compound annual growth rate of 6.6% from 2026 to 2031.

What factors are driving growth in Rest Of GCC Countries?

Rest Of GCC Countries' market growth is driven by government diversification initiatives, increased healthcare expenditure, and rising investments in biopharmaceutical research infrastructure.

Why is Rest Of GCC Countries important for protein expression development?

Rest Of GCC Countries is emerging as a regional hub for biopharmaceutical development with strong government support and growing capacity for advanced protein expression technologies.

RESEARCH METHODOLOGY

This study involved four major activities in estimating the current size of the protein expression market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory (GLOBOCAN), Centers for Disease Control and Prevention (CDC), and European Federation of Biotechnology,. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global protein expression market, and the findings were validated through primary research.

Primary Research

In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Protein Expression Market
Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the protein expression market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Protein Expression Market : Top-Down and Bottom-Up Approach

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.

Market Definition

The protein expression market encompasses the technologies, products, and services required for protein production and analysis. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes such as purification and characterization. It serves industries such as pharmaceuticals, biotechnology, academic & research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as other industries such as food and beverages, cosmetics, and textiles, among others.

Key Stakeholders

Protein Expression Instrument & Reagent Manufacturers
Suppliers of Expression Systems
National and regional research boards and organizations
Research & development companies
Clinical research organizations (CROs)
Contract Manufacturing Organizations (CMOs)
Biotechnology companies
Research laboratories & academic institutes
Market research & consulting firms
Regulatory bodies

Report Objectives

To define, describe, and forecast the protein expression market by offering, type, workflow, scale of operation, protein modality, application, product end user, service end user, and region
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall protein expression market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC (Saudi Arabia, United Arab Emirates, and the Rest of GCC) and the Rest of Middle East], and Africa
To profile the key players and analyze their market shares and core competencies
To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Customization Options

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

Further breakdown of the Rest of Europe protein expression market, by country
Further breakdown of the Rest of Asia Pacific protein expression market, by country

Segment Analysis

Cross-segment analysis

Get the Full Protein Expression Market Report

Full forecast, segment splits, and company analysis for all Protein Expression Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)